Home › Funds › Kynam Capital Management, LP › VERA

Kynam Capital Management, LP position in VERA

VERA THERAPEUTICS INC · Health Care

Kynam Capital Management, LP reported holding 3,000,000 shares of VERA (VERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$96.9M, representing 5.36% of its reported portfolio and ranking #9 among its reported holdings. Kynam Capital Management, LP has disclosed VERA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.00M sh
Reported value held$96.87M
Portfolio Weight5.36%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's VERA position evolved

Kynam Capital Management, LP first disclosed a stake in VERA in Q3 2023 at 2,956,053 shares (US$40.5M). The position peaked in Q4 2025 at 3,433,051 shares, worth US$173.8M. Across 13 filings, Kynam Capital Management, LP increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,000,000 shares valued at US$96.9M — an increase of 109,941 shares quarter over quarter.. Notable position changes include a 58% trim in Q1 2024 (shares fell 16% over the following quarter), a 65% increase in Q1 2025 (shares fell 2% over the following quarter), a 43% increase in Q2 2025 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.96M $40.53M New
Q4 2023 3.65M $56.14M Add
Q1 2024 1.53M $65.84M Reduce
Q2 2024 1.54M $55.85M Add
Q3 2024 1.58M $69.68M Add
Q4 2024 1.46M $61.66M Reduce
Q1 2025 2.40M $57.65M Add
Q2 2025 3.43M $80.74M Add
Q3 2025 4.03M $117.05M Add
Q4 2025 3.43M $173.85M Reduce
Q1 2026 3.40M $136.71M Reduce
Q2 2026 2.89M $124.01M Reduce
Q3 2026 3.00M $96.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VERA and 13F data

VERA (VERA THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in VERA — the largest reported positions include Deep Track Capital, LP (US$226.0M), Avoro Capital Advisors LLC (US$182.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VERA

All VERA fund holders →

FAQ

How long has Kynam Capital Management, LP held VERA?

Kynam Capital Management, LP has disclosed VERA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kynam Capital Management, LP's current position in VERA?

As of Q3 2026, Kynam Capital Management, LP holds 3.00M shares of VERA (VERA THERAPEUTICS INC), valued at $96.87M, representing 5.36% of its reported portfolio and ranking #9.

Has Kynam Capital Management, LP been buying or selling VERA?

In the latest 13F filing (Q3 2026), Kynam Capital Management, LP increased its position in VERA. The position peaked in Q4 2025 at 3.43M shares.

Which other funds hold VERA?

Other major institutional holders of VERA include Deep Track Capital, LP, Avoro Capital Advisors LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.